$ACHV News

Achieve Life Sciences Presents 52-Week Cytisinicline Results for Smoking and Vaping Cessation at CHEST 2026

Achieve Life Sciences Appoints Kaitlyn Tuson as Senior Vice President, Marketing and Communications

Achieve Life Sciences Announces Granting of New Hire Inducement Awards

Achieve Life Sciences Appoints Benjamin Halladay as Chief Financial Officer

Achieve Life Sciences Appoints Benjamin Halladay CFO, Effective Oct. 5

Stifel Initiates Coverage On Achieve Life Sciences with Buy Rating, Announces Price Target of $18

Achieve Life Sciences to Present 52-Week Cytisinicline Efficacy Data for Smoking and E-Cigarette Cessation at CHEST 2026

Achieve Life Sciences: Thesis Intact, Setup Remains Constructive (Rating Downgrade)

Achieve Life Sciences: A Funded Manufacturing Reset, Not A Broken Clinical Thesis

ACHV: Looking Ahead to Resubmission

Achieve Life Sciences Enters ATM Sale Agreement With Jefferies For Up To $150M In Common Stock

Morgan Stanley Initiates Coverage On Achieve Life Sciences with Overweight Rating, Announces Price Target of $13

Achieve Life Sciences Stock Has Nearly Tripled in the Last Year. Now It Just Needs to Turn a Profit.

Achieve Life Sciences Reports Second Quarter 2026 Financial Results and Provides Business Updates

Achieve Life Sciences Q2 EPS $(0.80) Misses $(0.16) Estimate

Achieve Life Sciences Appoints Ronald Dadino and Gloria Cosgrove to Lead CMC, Supply Chain, and Quality

Achieve Life Sciences Announced Granting of New Hire Inducement Awards

Achieve Life Sciences Stockholders Weigh Board Slate, Share Increase at Annual Meeting

Achieve Life Sciences: Despite CRL, A Success Is Achieve-Able

Achieve Life Sciences Joins Russell 2000® Index